Alexander Averyanov

First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline

Alexander Averyanov, Mikhail Konoplyannikov, V. A. Revkova et al. · Stem Cells Translational Medicine · 2019 · 165 citations · Full text

Medicine, Cell Biology, Cell Therapy +13

Status and initial physics performance studies of the MPD experiment at NICA

Vahagn Abgaryan, R. Acevedo Kado, Sergey Afanasyev et al. · The European Physical Journal A · 2022 · 101 citations · Full text

Natural Sciences, Physics, Experimental Performance +8

Tissue Engineered Neural Constructs Composed of Neural Precursor Cells, Recombinant Spidroin and PRP for Neural Tissue Regeneration

Vladimir A. Kalsin, N. N. Sovetnikov, Ekaterina M. Samoilova et al. · Scientific Reports · 2019 · 59 citations · Full text

Engineering, Bioengineering, Biotechnology +17

Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial

V. V. Rafalsky, Alexander Averyanov, B. Ya. Bart et al. · International Journal of Infectious Diseases · 2016 · 33 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Association of polymorphic markers of genes <i>FTO</i> , <i>KCNJ11, CDKAL1, SLC30A8,</i> and <i>CDKN2B</i> with type 2 diabetes mellitus in the Russian population

Aleksey Nikitin, Viktor Y. Potapov, Olga Brovkina et al. · PeerJ · 2017 · 32 citations · Full text

Medicine, Genetics, Molecular Genetics +15